We are live on ! Find out more
AYTU icon

AYTU BioPharma
AYTU

57 hedge funds and large institutions have $14M invested in AYTU BioPharma in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more capital invested

Capital invested by funds: $12.4M → $14M (+$1.62M)

5% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 19

0.01% more ownership

Funds ownership: 0.04% → 0.05% (+0.01%)

14% less funds holding

Funds holding: 66 → 57 (-9)

60% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 15

Holders
57
Holders Change
-9
Holders Change %
-13.64%
% of All Funds
1.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
20
Reduced
19
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.4M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.98M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$395K
4
Northern Trust
Northern Trust
Illinois
+$212K
5
Charles Schwab
Charles Schwab
California
+$77.9K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$326K
2
Jane Street
Jane Street
New York
-$301K
3
N
Nuveen
North Carolina
-$142K
4
Two Sigma Investments
Two Sigma Investments
New York
-$138K
5
VF
Virtu Financial
New York
-$138K
Name Holding Trade Value Shares
Change 		Change in
Stake
APA
51
American Portfolios Advisors
New York
$2.38K -$3.34K -13 -57%
AIP
52
Ameritas Investment Partners
Nebraska
$2K – – –
KFS
53
Kelly Financial Services
Massachusetts
$1.45K – – –
Citigroup
54
Citigroup
New York
$1K -$2.31K -9 -60%
Bank of Montreal
55
Bank of Montreal
Ontario, Canada
$1K -$1.03K -4 -44%
OIA
56
Optimum Investment Advisors
Illinois
$1K – – –
FWM
57
Focused Wealth Management
New York
$1K +$514 +2 +100%
Two Sigma Investments
58
Two Sigma Investments
New York
– -$138K -487 Closed
VF
59
Virtu Financial
New York
– -$138K -485 Closed
Renaissance Technologies
60
Renaissance Technologies
New York
– -$94K -330 Closed
Millennium Management
61
Millennium Management
New York
– -$85K -299 Closed
Squarepoint
62
Squarepoint
New York
– -$60K -213 Closed
UBS Group
63
UBS Group
Switzerland
– -$33.4K -130 Closed
BCM
64
Bayesian Capital Management
New York
– -$31K -108 Closed
HWA
65
HCR Wealth Advisors
California
– -$28K -100 Closed
WWM
66
Western Wealth Management
Colorado
– -$23K -83 Closed
GPFA
67
Game Plan Financial Advisors
Ohio
– -$18K -65 Closed
SG Americas Securities
68
SG Americas Securities
New York
– -$18K -62 Closed
CA
69
Cornerstone Advisory
Maryland
– -$16K -55 Closed
PAG
70
Private Advisor Group
New Jersey
– -$7K -23 Closed
AF
71
Advisornet Financial
Minnesota
– -$1K -3 Closed
1 2
3

AYTU Hedge Fund Activity: Q3 2020 in Review

57 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AYTU BioPharma (AYTU) for Q3 2020, worth a combined $14M — up 13% from $12.4M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of AYTU and 6 opened new positions — a net loss of 9 holders — while 19 trimmed existing stakes and 20 added.

The largest buyer was BlackRock, adding an estimated $2.4M. The largest seller was Bank of America, cutting an estimated $326K.

  • 57 institutional investors held AYTU BioPharma (AYTU) as of Q3 2020, down from 66 in Q2 2020.
  • Funds reported $14M of AYTU BioPharma stock for Q3 2020, up 13% quarter-over-quarter.
  • 6 funds opened new AYTU BioPharma positions in Q3 2020 and 15 closed out, a net change of -9 holders.
  • The largest AYTU BioPharma buyer in Q3 2020 was BlackRock, an estimated $2.4M added.
  • The largest AYTU BioPharma seller in Q3 2020 was Bank of America, an estimated $326K sold.

Based on aggregated 13F filings for Q3 2020.